Nael Abdelsamad

Nael Abdelsamad, a physician and director of research at Cleveland Clinic Abu Dhabi, shares his insights on transforming clinical trials through technology. He discusses the shift towards decentralized clinical trials in the post-pandemic era, highlighting both their potential and the challenges of integration. Nael emphasizes the importance of harnessing AI and machine learning to enhance patient experiences while minimizing administrative burdens. He also addresses the need for streamlined tech solutions and workforce development to foster a more efficient trial landscape.